Egrifta Tracker App
Track Your Egrifta Protocol
Egrifta (Tesamorelin) is a ghrh analogue, FDA approved, used in HIV lipodystrophy with Visceral fat -15% weight loss. Shotlee is the free app to track your complete Egrifta protocol — doses, side effects, weight, and labs.
25,000+
Active Users
4.8★
App Rating
Free
Always Free
What Is Egrifta?
Egrifta (Tesamorelin) is a ghrh analogue, FDA approved, used in HIV lipodystrophy with Visceral fat -15% weight loss. Shotlee is the free app to track your complete Egrifta protocol — doses, side effects, weight, and labs.
Shotlee tracks every aspect of your Egrifta protocol: injection dates, doses, sites, side effects, weight changes, and lab results. Whether you are starting or optimizing, clean data makes better decisions.
What to Track in Shotlee
Build a complete Egrifta protocol record from day one.
Dose Log
Record every injection date, dose amount, and administration route.
Weekly Weight
Track body weight consistently to see your response curve over time.
Side Effects
Log any side effects with severity ratings to share with your prescriber.
Lab Results
Save blood work and biomarkers from clinic visits in one place.
Measurements
Waist, hip, and other measurements reveal changes the scale may miss.
Notes & Mood
Daily notes on energy, appetite, sleep, and overall wellbeing.
How to Track Your Egrifta Protocol
Set a baseline: log your starting weight, measurements, and any available labs before your first dose
Record every dose: date, amount, injection site, and any immediate reactions
Log weekly weight at the same time and conditions to track your trend
Note side effects with severity so your prescriber can adjust your protocol
Add lab results from each clinic visit to measure biomarker improvements over time
Egrifta Key Facts
Status
FDA Approved
Approved 2010
Typical Dose
2 mg SC
2 mg SC daily
Protocol FAQs
Clinical studies showed significant visceral fat reduction after 26 weeks of daily use. Consistency is key, and Shotlee helps you stay on track.
Yes! Many users stack Tesamorelin (a GHRH) with Ipamorelin (a GHRP) for synergistic growth hormone release. Shotlee allows tracking multiple peptides.
Open the Shotlee app, navigate to the dose logging screen, select Tesamorelin as your medication, and enter the dose amount, injection site, and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts. The app is free to download and use.
The most important side effects to track include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), injection site reactions, appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider at your next visit.
Most patients begin noticing appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule and individual metabolic response. Track your weekly weight in Shotlee to visualize your personal response curve over time.
References
- [1]Clinical TrialFalutz J et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-2370.
- [2]Clinical TrialStanley TL et al. Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients (LIPO-T). Lancet HIV. 2019;6(3):e154-e163.
Track Your Egrifta Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.
🚀 Use Shotlee for Free